CEPI-a new global R&D organisation for epidemic preparedness and response

Affiliations

¹ Ministry of Foreign Affairs, Oslo, Norway.
² Wellcome Trust, London, UK.
³ Ministry of Health, Kigali, Rwanda.
⁴ Directorate-General for Research and Innovation, European Commission, Brussels, Belgium.
⁵ Bill & Melinda Gates Foundation, Seattle, WA, USA.
⁶ Ministry of Health, Labour, and Welfare, Tokyo, Japan.
⁷ Ministry of Science and Technology, New Delhi, India.
⁸ Federal Ministry of Education and Research, Berlin, Germany.
⁹ CEPI-Coalition for Epidemic Preparedness Innovations, c/o Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway; Norwegian Institute of Public Health, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway; Harvard T H Chan School of Public Health, Boston, USA. Electronic address: john-arne.rottingen@fhi.no.

Børge Brende et al. Lancet. 2017.

. 2017 Jan 21;389(10066):233-235.

doi: 10.1016/S0140-6736(17)30131-9. Epub 2017 Jan 19.

¹ Ministry of Foreign Affairs, Oslo, Norway.
² Wellcome Trust, London, UK.
³ Ministry of Health, Kigali, Rwanda.
⁴ Directorate-General for Research and Innovation, European Commission, Brussels, Belgium.
⁵ Bill & Melinda Gates Foundation, Seattle, WA, USA.
⁶ Ministry of Health, Labour, and Welfare, Tokyo, Japan.
⁷ Ministry of Science and Technology, New Delhi, India.
⁸ Federal Ministry of Education and Research, Berlin, Germany.
⁹ CEPI-Coalition for Epidemic Preparedness Innovations, c/o Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway; Norwegian Institute of Public Health, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway; Harvard T H Chan School of Public Health, Boston, USA. Electronic address: john-arne.rottingen@fhi.no.

No abstract available

Figures

1. Gostin LO, Tomori O, Wibulpolprasert S. Toward a common secure future: four global commissions in the wake of Ebola. PLoS Med. 2016;13:e1002042. - PMC - PubMed
1. Kieny MP, Røttingen JA, Farrar J, on behalf of the WHO R&D Blueprint team the R&D Blueprint Scientific Advisory Group The need for global R&D coordination for infectious diseases with epidemic potential. Lancet. 2016;388:460–461. - PMC - PubMed
1. Matthiessen L, Colli W, Delfraissy JF, Hwang ES, Mphahlele J, Ouellette M, on behalf of GloPID-R members Coordinating funding in public health emergencies. Lancet. 2016;387:2197–2198. - PubMed
1. Henao-Restrepo AM, Longini IM, Egger M. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857–866. - PubMed
1. Henao-Restrepo AM, Camacho A, Longini IM. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) Lancet. 2016 doi: 10.1016/S0140-6736(16)32621-6. published online first Dec 22. - DOI - PMC - PubMed